









Markets
/
Stocks
/
nasdaq-alc
/

Alcon AG

ALC

77.410USD

-0.880-1.12%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

38.29BMarket Cap

34.18P/E TTM



Alcon AG

77.410

-0.880-1.12%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-12

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

54 / 207

Overall Ranking

179 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 19 analysts

Buy

Current Rating

98.728

Target Price

+26.11%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 203.88.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 15.23%.

Undervalued

The company’s latest PE is 34.58, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 340.08M shares, decreasing 10.27% quarter-over-quarter.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.26.

Financial Health

Currency: USD Updated：2025-09-12

The company's current financial score is 6.27, which is lower than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 2.47B, representing a year-over-year increase of 0.57%, while its net profit experienced a year-over-year increase of 41.13%.

Score

Industry at a Glance

Previous score

6.27

Change



Financials

2.10

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.30

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.53

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.28

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.11

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-12

The company’s current valuation score is 4.80, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 35.94, which is 124.36% below the recent high of 80.64 and -12.91% above the recent low of 40.58.

Score

Industry at a Glance

Previous score

4.01

Change

-0.01

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 54/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-12

The company’s current earnings forecast score is 8.67, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Alcon AG is 100.00, with a high of 123.00 and a low of 80.00.

Score

Industry at a Glance

Previous score

8.42

Change

Support & Resistance

No Data

Analyst Rating

Based on 19 analysts

Buy

Current Rating

98.728

Target Price

+26.11%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Alcon AG

ALC

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-12

The company’s current price momentum score is 7.07, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 88.48 and the support level at 76.18, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.61

Change

0.06

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.027

Sell

RSI(14)

37.167

Neutral

STOCH(KDJ)(9,3,3)

17.932

Sell

ATR(14)

1.381

High Vlolatility

CCI(14)

-119.027

Sell

Williams %R

98.879

Oversold

TRIX(12,20)

-0.396

Sell

StochRSI(14)

19.898

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

78.426

Sell

MA10

78.817

Sell

MA20

80.574

Sell

MA50

84.827

Sell

MA100

87.266

Sell

MA200

88.023

Sell

Institutional Confidence

Currency: USD Updated：2025-09-12

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Advisors (UK) Limited

24.68M

The Vanguard Group, Inc.

Star Investors

19.86M

+2.63%

Aristotle Capital Management, LLC

12.23M

-4.73%

UBS Fund Management (Switzerland) AG

11.54M

-3.34%

Norges Bank Investment Management (NBIM)

12.62M

+2.24%

Zürcher Kantonalbank (Asset Management)

8.51M

-4.67%

AKO Capital LLP

7.12M

+21.09%

Harding Loevner LP

7.12M

-15.94%

T. Rowe Price Associates, Inc.

Star Investors

4.92M

+5697.04%

Risk Assessment

Currency: USD Updated：2025-09-12

The company's beta value is 0.98. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.